Molecular profiling of meningioma can lead to improved prognosis and therapy
Integrating multiple molecular profiling approaches of meningioma, the most common primary brain tumor, could transform patient care by providing a better prognosis and revealing the tumors that require more aggressive treatment.
Materials provided by Baylor College of Medicine. Original written by Graciela Gutierrez. Note: Content may be edited for style and length.
Source link aaaaa